Advanced Biomed Inc Earnings Per Share (Basic)
Advanced Biomed Inc (ADVB) reported Earnings Per Share (Basic) of -$0.38 per share for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-05-15
- Advanced Biomed Inc earnings per share, basic for the quarter ending 2026-03-31 was -$0.38.
- Advanced Biomed Inc earnings per share, basic for the quarter ending 2025-12-31 was $0.31.
- Advanced Biomed Inc earnings per share, basic for the quarter ending 2025-09-30 was -$0.02.
- Advanced Biomed Inc earnings per share, basic for the quarter ending 2025-06-30 was -$0.01.
- Advanced Biomed Inc earnings per share, basic for fiscal 2025 was -$0.16.
- Advanced Biomed Inc earnings per share, basic for fiscal 2024 was -$0.14.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | -$0.38 10-Q · filed 2026-05-15 | $0.56 derived: net income ÷ weighted average shares · filed 2026-05-15 | $5.21 10-Q · filed 2026-05-15 | $0.17 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2025-12-31 | $0.31 10-Q · filed 2026-02-13 | $0.30 10-Q · filed 2026-02-13 | $0.14 derived: net income ÷ weighted average shares · filed 2026-02-13 | $0.14 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2025-09-30 | -$0.02 10-Q · filed 2025-11-19 | -$0.02 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-05-15 | ||
| 2025-06-30 | -$0.01 derived: net income ÷ weighted average shares · filed 2025-10-08 | -$0.05 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.09 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$0.16 10-K · filed 2025-10-08 | ||
| 2025-03-31 | -$1.35 10-Q · filed 2026-05-15 | -$0.07 10-Q · filed 2025-05-15 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-05-15 | -$2.54 10-Q · filed 2026-05-15 | -$0.13 10-Q · filed 2025-05-15 | -$0.22 derived: net income ÷ weighted average shares · filed 2026-05-15 |
| 2024-12-31 | -$0.05 10-Q · filed 2026-02-13 | -$0.04 10-Q · filed 2025-04-15 | -$0.06 10-Q · filed 2026-02-13 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-02-13 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-02-13 | |
| 2024-09-30 | -$0.01 10-Q · filed 2025-11-19 | -$0.05 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-11-19 | -$0.11 derived: net income ÷ weighted average shares · filed 2025-11-19 | ||
| 2024-06-30 | -$0.04 derived: net income ÷ weighted average shares · filed 2025-10-08 | -$0.09 derived: net income ÷ weighted average shares · filed 2025-10-08 | -$0.10 derived: net income ÷ weighted average shares · filed 2025-10-08 | -$0.14 10-K · filed 2025-10-08 | ||
| 2024-03-31 | -$0.05 10-Q · filed 2025-05-15 | -$0.06 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$0.10 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | -$0.01 10-Q · filed 2025-04-15 | -$0.05 10-Q · filed 2025-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |